Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on May 9, 2025
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 9, 2025
Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data expected in 4Q25 KT-579 (IRF5) new …
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 9, 2025
Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 development candidate nomination and IND filing …
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
GlobeNewswire
·
May 9, 2025
FRIENDSWOOD, Texas, May 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the first independent validation of the recently …
Vireo Growth Inc. Announces First Quarter 2025 Results
GlobeNewswire
·
May 9, 2025
– Q1 revenue of $24.5 million increased 1.9% year-over-year, in line with expectations for Vireo’s established markets – – Merger Transactions expected to begin closing in Q2 and further strengthen profitability profile – MINNEAPOLIS, May 09, 2025 (GLOBE …
InspireMD Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first …
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
GlobeNewswire
·
May 9, 2025
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4% Total Rare Disease quarterly net revenues of $69.0 million, which includes: Purified Cortrophin® Gel net revenues of $52.9 million, an increase of 43.1% …
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
GlobeNewswire
·
May 9, 2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, presented …
Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting
GlobeNewswire
·
May 9, 2025
First small molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI improvements in Phase 2a in patients with …
Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025
GlobeNewswire
·
May 9, 2025
Oral dual-targeted ABCB4/BSEP positive functional modulator (PFM) improved cholestatic and cholangitis markers in orthogonal models of hepatobiliary disease Data reinforce the potential of this differentiated mechanism of action (MOA) to address the core …
Sanuwave Announces Q1 FY2025 Financial Results
GlobeNewswire
·
May 9, 2025
Q1 2025 revenues were $9.3 million, up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 gross margin was 79.0%, versus 72.6% in Q1 2024. GAAP Operating Income was $1.0 million for Q1 2025, an …
Florida Governor Ron DeSantis Joins Olympia Pharmaceuticals in Ribbon-Cutting Ceremony for New Sister Pharmacy, Wesley Pharmaceuticals
GlobeNewswire
·
May 9, 2025
ORLANDO, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- Wesley Pharmaceuticals, a state-of-the-art 503B compounding facility and Olympia Pharmaceuticals' new sister brand, proudly celebrated its grand opening with a ribbon-cutting ceremony and facility tour at its …
RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025
GlobeNewswire
·
May 9, 2025
LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced …
Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 9, 2025
Q1 2025 revenue of $22.1 million; GAAP basic EPS: $0.03 Completed data collection and achieved database lock for the pivotal Phase 3 trial of Hydronidone in Chronic Hepatitis B (“CHB”)-associated liver fibrosis; currently reviewing data and on track to …
SlimJaro Complaints Investigated: 2025 User Reviews Tested & Verified
GlobeNewswire
·
May 9, 2025
LAKELAND, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- Introduction: The 2025 Weight Crisis – Why So Many People Struggle to Slim Down In 2025, individuals across all continents face one strikingly common struggle: stubborn weight gain that doesn’t respond to …
Sumatra Slim Belly Tonic Reviews: What Users Are Saying About This Blue Tonic for Weight Loss
GlobeNewswire
·
May 9, 2025
HOUSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight today can feel like a bigger challenge than ever before. Despite trying endless diets, workout plans, and the latest supplements, many of us still struggle with stubborn belly fat that just won't …
ProstaVive Reviews 2025 (New Medical Report): Shocking User Results, Key Ingredients & Complaints
GlobeNewswire
·
May 9, 2025
DALLAS, May 09, 2025 (GLOBE NEWSWIRE) -- As prostate health becomes a growing concern for millions of aging men, ProstaVive has quickly risen to prominence, dominating conversations across wellness forums, trending on social media, and grabbing the …
ProDentim Reviews and Complaints (May 2025): Users Share Results and Address Common Concerns
GlobeNewswire
·
May 9, 2025
BIRMINGHAM, Ala., May 09, 2025 (GLOBE NEWSWIRE) -- ProDentim has quickly become a popular probiotic supplement in the oral health world, but with so many health trends, it's natural to wonder if it’s effective. Over 30,000 users have shared positive …
Imprivata ernennt Joel Burleson-Davis zum neuen Chief Technology Officer
GlobeNewswire
·
May 9, 2025
LANGENFELD, Germany, May 09, 2025 (GLOBE NEWSWIRE) -- Imprivata, das führende Unternehmen für digitale Identitäten in kritischen Branchen, wie dem Gesundheitswesen, hat Joel Burleson-Davis, seinen bisherigen Senior Vice President Engineering for …